- Home
- GHRS vs MBLY Comparison
GHRS vs MBLY Comparison
Compare GHRS & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | MBLY |
|---|---|---|
| Founded | 2018 | 1999 |
| Country | Ireland | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | GHRS | MBLY |
|---|---|---|
| Price | $29.08 | $8.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 20 |
| Target Price | ★ $41.38 | $14.13 |
| AVG Volume (30 Days) | 304.9K | ★ 7.5M |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.43 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,894,000,000.00 |
| Revenue This Year | N/A | $4.91 |
| Revenue Next Year | N/A | $13.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.51 |
| 52 Week Low | $11.83 | $6.47 |
| 52 Week High | $31.44 | $15.81 |
Technical Indicators
Market Signals| Indicator | GHRS | MBLY |
|---|---|---|
| Relative Strength Index (RSI) | 62.73 | 52.25 |
| Support Level | $12.83 | $8.43 |
| Resistance Level | $31.00 | $10.41 |
| Average True Range (ATR) | 1.39 | 0.49 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 72.08 | 88.92 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Moovit. The solutions provided by the company are: Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.